HHS has submitted the proposed rule on Meaningful Use Stage 3 to the Office of Management and Budget (OMB). Review by OMB is usually the last step before a proposed rule is published in the Federal Register. Stage 3 is (currently) scheduled to start no earlier than 2017, so most of the proposed requirements in this rule should pertain only to 2017 and beyond. According to the summary on OMB’s site, the Stage 3 proposed rule will include “changes to the reporting period, timelines, and structure of the program,” and those changes “will provide a flexible, yet, clearer framework to ensure future sustainability of the EHR program and reduce confusion stemming from multiple stage requirements.”
Impact Advisors’ Thoughts: Assuming we’re reading the OMB site correctly, it looks as though the Stage 3 proposed rule is scheduled to be published in the Federal Register sometime in February 2015 (!), which would mean the final rule could very well be released this fall. As for the “flexible, clearer” MU framework promised, well, we really hope this is the case.
A new report from KLAS looks at the emerging Population Health Management (PHM) market. KLAS found that most vendors (including both core EHR and niche vendors) currently have only a limited number of clients live on PHM, and only a minority of provider clients surveyed said they are using a solution that covers all four of the major population health areas defined by KLAS (data aggregation, risk stratification, care management, and patient engagement). Although the market is still maturing, providers using PHM are reporting results, with 70% of respondents saying that their organization has seen tangible benefits since go-live of the PHM product. [See the graphic below from KLAS’ website for more details.]
(Source: “Population Health Performance: Emerging Market, Emerging Value,” KLAS Research, December 2014)
Impact Advisors’ Thoughts: There is a tremendous amount of detail in this report, and it is definitely recommended reading for organizations that have access. As time goes on, it will also be interesting to see 1) whether demand increases for products that offer a broader range of population health capabilities, and 2) how that might impact niche vendors (many of which experiencing success, but realistically are only focused on one or two elements of PHM).
For more on PHM, check out our white paper “Population Health Management Primer” available for download here.